Is It Time To Buy The Rebound In Johnson & Johnson? 

Published on January 26, 2022

Johnson & Johnson (NYSE: JNJ) shares are moving higher on a mixed report. The company missed on the top line but margins came in well above expectation and drove solid...

Continue reading on website
Other news

Infermedica raises $30M to expand its AI-based medical guidance platform

January 26, 2022
Infermedica, a Poland-founded digital health company that offers AI-powered solutions for symptom analysis and patient triage, has raised $30 million in Series B funding. The round was led by One Peak and included participation from previous investors Karma Ventures, European Bank for Reconstruction and Development, Heal Capital and Inovo Venture Partners. The new capital means the startup has rai

Best Solar Energy Stocks to Invest in This Year

January 26, 2022
Why not invest in solar? The technology will only continue to become more profitable as time goes on. Time for long-term investors to get moving!